Latest Warehousing News

Southern Cross Electrical Engineering Limited (SCEE) delivered record FY25 financials, driven by a 45% revenue jump and the recent Force Fire acquisition, setting the stage for robust FY26 growth.

Southern Cross Electrical Engineering (SCEE) has delivered a landmark FY25 with record revenue and earnings, boosted by its strategic acquisition of Force Fire and a robust order book. The company projects continued growth with an 18-24% rise in EBITDA for FY26.

Qube Holdings reveals significant non-cash impairments and provisions tied to its Moorebank Logistics Park Interstate Rail Terminal, while underlying earnings are expected to grow by at least 5% in FY25.

BP8 Indonesia has locked in a US$375,000 trade financing facility with Singapore’s Equenita Natural Resources, aiming to expand seaweed procurement and processing ahead of a new warehouse launch in Makassar.

RooLife Group Ltd has successfully raised $2 million through an oversubscribed strategic placement, positioning the company to expand its e-commerce footprint across key international markets.

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.

McPherson’s Limited anticipates FY25 revenue around $139 million with a strong second-half EBITDA rebound, while its strategic shift to third-party wholesalers sets the stage for significant EBIT gains in FY26.

The ACCC has approved DP World Australia’s acquisition of Silk Logistics, concluding it won’t significantly harm competition in container stevedoring and logistics services. The decision follows a thorough investigation into potential market impacts.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.